Liaoning Cheng Da Co., Ltd. operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Liaoning Cheng Da Co., Ltd. with three other
companies in this sector in China:
HPGC Renmintongtai Pharmaceutical Corp
sales of 8.91 billion Chinese Renmimbi [US$1.32 billion]
of which 94%
was Pharmaceutical Commerce),
Laobaixing Pharmacy Chain Joint Stock Co
(4.56 billion Chinese Renmimbi [US$677.40 million]
of which 95%
was Pharmaceutical retail), and
Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd
(5.32 billion Chinese Renmimbi [US$789.65 million]
of which 95%
was Retail Sale).
During the year ended December of 2015, sales at
Liaoning Cheng Da Co., Ltd. were 9.13 billion Chinese Renmimbi (US$1.36 billion).
decrease of 1.1%
versus 2014, when the company's sales were 9.23 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 54.3% decline
in Energy Research, from 269.28 million Chinese Renmimbi to 123.11 million Chinese Renmimbi.
There were also decreases in sales in
Trade (down 2.2% to 5.30 billion Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Medicines Sales (up 6.5% to 2.76 billion Chinese Renmimbi)
Drugs Manufacturing (up 0.7% to 943.42 million Chinese Renmimbi)
Headquarter Office (up 215.7% to 38.76 million Chinese Renmimbi)